BMJ:春夏出生女性人群的心血管特异性死亡风险高于秋冬季

2019-12-20 MedSci MedSci原创

研究发现,春夏出生女性人群的心血管特异性死亡风险高于秋冬季

近日研究人员评估了出生月份和季节与总体死亡率和心血管疾病死亡率之间的关系。

研究开始于1976年,116911名女性护士参与研究,随访38年,采用Cox比例风险模型评估年龄、出生月份(以11月为参考)、出生季节(以秋季为参考)与总体死亡率和心血管疾病特异性死亡率之间的关系。

研究期间,43248人死亡,包括8360例心血管疾病相关死亡。在完全调整的多变量分析中,没有观察到出生月份、出生季节和总死亡率之间的显著关联。但与11月份出生的女性相比,3-7月份出生的妇女心血管疾病死亡率增加(3月份的危险比为1.09;4月份的危险比为1.12;5月份的危险比为1.08;6月份的危险比为1.07;7月份的危险比为1.08)。4月份出生者人群的心血管疾病死亡率最高,12月份出生者最低(12月份,0.95)。最低风险月与最高风险月份的相对差异为17.89%。春季(1.10)和夏季(1.09)出生女性的心血管疾病死亡率高于秋季,最低风险季节与最高风险季节的相对差异为10.00%。

研究发现,春夏出生女性人群的心血管特异性死亡风险高于秋冬季。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1848921, encodeId=d0c81848921ed, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Mar 20 22:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802059, encodeId=f42a18020595b, content=<a href='/topic/show?id=8b7de4762c2' target=_blank style='color:#2F92EE;'>#秋冬季#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74762, encryptionId=8b7de4762c2, topicName=秋冬季)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue Oct 20 07:54:00 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899348, encodeId=bdcc189934856, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Feb 21 14:54:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255933, encodeId=c32d1255933f5, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Dec 22 09:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377219, encodeId=0b493e72197b, content=学习了谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Dec 20 20:48:10 CST 2019, time=2019-12-20, status=1, ipAttribution=)]
    2020-03-20 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1848921, encodeId=d0c81848921ed, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Mar 20 22:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802059, encodeId=f42a18020595b, content=<a href='/topic/show?id=8b7de4762c2' target=_blank style='color:#2F92EE;'>#秋冬季#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74762, encryptionId=8b7de4762c2, topicName=秋冬季)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue Oct 20 07:54:00 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899348, encodeId=bdcc189934856, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Feb 21 14:54:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255933, encodeId=c32d1255933f5, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Dec 22 09:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377219, encodeId=0b493e72197b, content=学习了谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Dec 20 20:48:10 CST 2019, time=2019-12-20, status=1, ipAttribution=)]
    2020-10-20 szhvet
  3. [GetPortalCommentsPageByObjectIdResponse(id=1848921, encodeId=d0c81848921ed, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Mar 20 22:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802059, encodeId=f42a18020595b, content=<a href='/topic/show?id=8b7de4762c2' target=_blank style='color:#2F92EE;'>#秋冬季#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74762, encryptionId=8b7de4762c2, topicName=秋冬季)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue Oct 20 07:54:00 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899348, encodeId=bdcc189934856, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Feb 21 14:54:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255933, encodeId=c32d1255933f5, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Dec 22 09:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377219, encodeId=0b493e72197b, content=学习了谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Dec 20 20:48:10 CST 2019, time=2019-12-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1848921, encodeId=d0c81848921ed, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Mar 20 22:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802059, encodeId=f42a18020595b, content=<a href='/topic/show?id=8b7de4762c2' target=_blank style='color:#2F92EE;'>#秋冬季#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74762, encryptionId=8b7de4762c2, topicName=秋冬季)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue Oct 20 07:54:00 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899348, encodeId=bdcc189934856, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Feb 21 14:54:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255933, encodeId=c32d1255933f5, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Dec 22 09:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377219, encodeId=0b493e72197b, content=学习了谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Dec 20 20:48:10 CST 2019, time=2019-12-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1848921, encodeId=d0c81848921ed, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Fri Mar 20 22:54:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1802059, encodeId=f42a18020595b, content=<a href='/topic/show?id=8b7de4762c2' target=_blank style='color:#2F92EE;'>#秋冬季#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74762, encryptionId=8b7de4762c2, topicName=秋冬季)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec37461, createdName=szhvet, createdTime=Tue Oct 20 07:54:00 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899348, encodeId=bdcc189934856, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Fri Feb 21 14:54:00 CST 2020, time=2020-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255933, encodeId=c32d1255933f5, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sun Dec 22 09:54:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377219, encodeId=0b493e72197b, content=学习了谢谢分享学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Fri Dec 20 20:48:10 CST 2019, time=2019-12-20, status=1, ipAttribution=)]
    2019-12-20 一个字-牛

    学习了谢谢分享学习

    0

相关资讯

JACC:完全血运重建可以降低远期不良事件发生风险

随机临床试验已经证实ST段抬高型心梗伴多支血管病变患者接受完全的血运重建可以降低主要不良心血管事件(MACE)的发生风险。本研究的目的旨在评估完全血运重建的益处是否会持续至随访的远期。本研究纳入分析了CvLPRIT临床试验中的ST段抬高型心梗伴多支血管病变患者,经过平均5.6年时间的随访,完全血运重建组和仅重建梗死相关动脉组患者的MACE发生率分别是24%和37.7%(HR:0.57; 95% c

JACC:女性非ST段抬高型心梗患者不良事件发生率低于男性

非ST段抬高型急性冠脉综合征(NSTEACS)女性患者的不良事件发生率是否高于男性仍不确定,本研究的目的旨在评估NSTEACS患者预后的性别差异。本研究共纳入分析了68730名NSTEACS患者,其中19827名(29%)为女性,相比于男性患者,女性年龄更大,且发生高血压、糖尿病、心衰和肾功能不全的风险更大。在考虑混杂因素之前,女性和男性患者的主要心血管不良事件(MACE)发生率无明显差异([HR

Heart:急性和慢性心肌损伤远期预后的比较

本研究的目的旨在分析和比较急性和慢性心肌损伤的远期预后。本研究纳入了2011-2014在急诊接受了高敏肌钙蛋白T(hs-cTnT)检测的22589名患者, 并将hs-cTnT>14ng/L的患者挑出来,分成急性心肌损伤、1型心梗(T1MI)、2型心梗(T2MI)或慢性心肌损伤,主要终点事件是全因死亡率。最终,共纳入分析了3853名患者,经过平均3.9年时间的随访,急性心肌损伤、1型心梗、2型心梗和

JACC:颈动脉支架置入术的围手术期预后研究

本研究的目的旨在评估一组颈动脉支架置入术(CAS)治疗无症状和症状性颈动脉狭窄的围手术期结局。本研究纳入分析了无症状颈动脉狭窄≥70%和有症状≥50%的年龄≤80岁的颈动脉狭窄患者,主要终点事件是术后30天卒中和死亡的复合事件,次要终点事件是心梗和穿刺相关并发症。最终,共纳入分析了来自98个医学中心的2141名颈动脉狭窄患者,共有2219次CAS操作。患者平均年龄为68岁,男性占65%,白种人占9

JACC:空气污染与心脏移植后死亡风险呈相关性

接受心脏移植的患者死亡风险较高,传统的风险评分在预测移植后存活率方面表现一般,强调了尚未确定的因素在决定预后方面的重要性。本研究的目的旨在评估PM2.5的暴露与心脏移植死亡风险的相关性。本研究纳入分析了UNOS数据库中的21800名接受了心脏移植的患者,随访时间是86713人年,接受心脏移植时的平均年龄为52.6 ± 12.6岁,男性占75%,白种人占69%,39%有缺血性心力衰竭病因。平均对PM

盘点:JACC12月第二期研究一览

1. 术者经验与经导管二尖瓣修复术预后呈明显相关DOI: 10.1016/j.jacc.2019.09.014http://www.onlinejacc.org/content/74/24?current-issue=y经导管二尖瓣修复术(TMVr)是一类复杂的治疗二尖瓣反流的手术,本研究的目的旨在评估术者的操作经验与TMVr预后的相关性。本研究纳入分析了2013-2018年数据库中来自290个医